Login / Signup

Quality of Reporting Randomized Controlled Trials Published in Three of the Most Citable Periodontal Journals from 2018 to 2022.

Fahad AlharbiKhalid GufranMuzammil Moin AhmedAbdulaziz Mohammad AlsakrAbdullah Saleh Almutairi
Published in: Healthcare (Basel, Switzerland) (2023)
This study aimed to evaluate the reporting quality of randomized clinical trials (RCTs) in periodontology. Three leading periodontology journals, the Journal of Periodontology (JOP), the Journal of Clinical Periodontology (JOCP), and the Journal of Periodontal Research (JOPR), were selected for this investigation. The RCTs were identified by manually searching for human trial articles published in these three journals. Two authors independently conducted the literature search, and a pre-piloted extraction sheet was used to screen the potential RCTs. The CONSORT checklist guidelines were employed to calculate the score value. Intra-examiner reliability was assessed by scoring a random sample of 10% of the papers in a second round conducted by the first examiner three months after the initial data collection. A search of abstracts published over a five-year period yielded 176 articles that reported RCTs, accounting for 11.7% of all articles published in the three journals. The highest number of RCTs was published in 2020, and more than half of the included RCTs (51%) originated from Europe. Many of the analyzed RCTs inadequately reported almost half of the items on the CONSORT checklist. Furthermore, univariate analysis revealed significant associations between certain factors and the overall CONSORT score, such as publication in JOP ( p = 0.048), publication year of 2019 ( p = 0.041) and 2021 ( p = 0.042), first author from North America ( p = 0.016), and RCTs with more than six authors ( p = 0.042). Clinical trial research in periodontics has made significant progress in the past five years. However, there is room for improvement in adhering to the CONSORT guidelines.
Keyphrases
  • meta analyses
  • clinical trial
  • randomized controlled trial
  • systematic review
  • study protocol
  • endothelial cells
  • clinical practice
  • emergency department
  • phase iii
  • adverse drug
  • artificial intelligence
  • open label